0001493152-24-000154.txt : 20240102
0001493152-24-000154.hdr.sgml : 20240102
20240102190849
ACCESSION NUMBER: 0001493152-24-000154
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jayasuriya Anula
CENTRAL INDEX KEY: 0001822933
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 24503982
MAIL ADDRESS:
STREET 1: 5150 EL CAMINO REAL, SUITE #A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0508
4
2023-12-29
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001822933
Jayasuriya Anula
2173 SALK AVENUE, SUITE 200
CARLSBAD
CA
92008
1
0
0
0
0
Common Shares, no par value
2023-12-29
4
P
0
10000
1.09
A
10000
D
The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.08 to not more than $1.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.
/s/ Alexandra Hernandez, as Attorney-in Fact
2024-01-02